Prognostic relevance of MIB-1 immunoreac
โ
H. Struikmans; D.H. Rutgers; G.H. Jansen; H.F.J. Dullens; L. Oosten; C.A.F. Tull
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 127 KB
Prognostic relevance of cell proliferation markers was evaluated in 27 glioma patients. By 1) flow cytometry (FCM), i.e., S-phase fraction (SPF), and BrdUrdlabeling index (LI fcm ); 2) immunohistochemistry (IHC), i.e., BrdUrd-labeling index (LI ihc ) and MIB-1 immunoreactivity (MIB-1 LI ihc ); and 3